What is NDC 61314-504?

61314-504 is the product NDC for Enzeevu (aflibercept), Aflibercept 2 mg/.05mL injection, solution, listed with the FDA by Sandoz Inc. It has 1 package NDC, shown above in 10- and 11-digit form.

Sandoz Inc, NDC labeler code 61314. The labeler is the company responsible for the label; it may be the manufacturer, a repackager or a distributor.

What other NDCs exist for Enzeevu?

None: this is the only finished product listed under this name.

Is there a related HCPCS / J-code?

Yes: J0178, Injection, aflibercept, 1 mg.

Enzeevu NDC 61314-504 | National Drug Code

NDC codes

FDA NDC Directory

Product NDC (as listed)61314-504Labeler and product segments. Claims need a package NDC.

Product NDC at billing width61314-0504Add the package segment from the table below.

Package NDCs as listed with the FDA, and the 11-digit 5-4-2 form used on claims. The highlighted digit is the added leading zero.
Package NDC	11-digit (billing)	Package	Copy
61314-504-63	6131405046361314050463	1 SYRINGE, GLASS in 1 CARTON (61314-504-63) / .05 mL in 1 SYRINGE, GLASSMarketed from Oct 26, 2026

How the 11-digit form is made: The product segment has 3 digits, so one leading zero is added to it (5-3-2 → 5-4-2). Formatting the NDC does not by itself make it billable — the product, package and quantity must match what was dispensed or administered, and payer rules apply. Conversion rules

Product information

Brand name (proprietary): Enzeevu
Generic name (nonproprietary): aflibercept
Active ingredients: Aflibercept — 2 mg/.05mL
Dosage form: Injection, Solution
Route: Intravitreal
Labeler: Sandoz IncNDC labeler code 61314
Product type: Prescription drug
Marketing category: BLA — Biologics License ApplicationApplication BLA 761382
Marketing start: Oct 26, 2026
Listing expires: Dec 31, 2027
Other FDA classes: Vascular Endothelial Growth Factor Inhibitors (Mechanism)
Identifiers: Product ID 61314-504_6f1d28a8-1c10-40d2-83f0-6a528f807b92SPL ID 6f1d28a8-1c10-40d2-83f0-6a528f807b92SPL set ID 6f1d28a8-1c10-40d2-83f0-6a528f807b92RxCUI 2754974, 2754981UNII 15C2VL427D
Pharmacologic class: Vascular Endothelial Growth Factor Inhibitor

Billing references

What Med-Code can say about coding this product, and where each statement comes from. Nothing here is inferred from the name alone.

HCPCS codeMed-Code curated

J0178 — Injection, aflibercept, 1 mg

Billing unit: 1 mg. Units on the claim = dose given ÷ 1 mg.

EYLEA HD and aflibercept biosimilars have their own HCPCS codes.

Administration

Intravitreal injection procedure (CPT 67028)

The intravitreal injection is reported as a separate procedure from the drug supplied.

How CPT relates to drug billing

NDC on a medical claim

N461314050463 followed by a unit qualifier and the quantity

Package 61314-0504-63. Unit qualifiers: F2 (international unit), GR (gram), ME (milligram), ML (milliliter), UN (unit (each)). The qualifier and quantity depend on what was given. About the N4 qualifier

Product label

Current FDA label (SPL), effective Apr 24, 2026.

Indications (excerpt from the label)

ENZEEVU is indicated for the treatment of: ENZEEVU is a vascular endothelial growth factor (VEGF) inhibitor indicated for the treatment of patients with: • Neovascular (Wet) Age-Related Macular Degeneration (AMD) ( 1.1 ) • Macular Edema Following Retinal Vein Occlusion (RVO) ( 1.2 ) • Diabetic Macular Edema (DME) ( 1.3 ) • Diabetic Retinopathy (DR) ( 1.4 ) 1.1 Neovascular (Wet) Age-Related Macular Degeneration (AMD) 1.2 Macular Edema Following Retinal Vein Occlusion (RVO) 1.3 Diabetic Macular Edema (DME) 1.4 Diabetic Retinopathy (DR)

Excerpt only. Read the full label for complete information.

Full label on DailyMed (opens in a new tab)

About NDC 61314-504

What is NDC 61314-504?: 61314-504 is the product NDC for Enzeevu (aflibercept), Aflibercept 2 mg/.05mL injection, solution, listed with the FDA by Sandoz Inc. It has 1 package NDC, shown above in 10- and 11-digit form.
What drug is associated with this NDC?: Enzeevu (Aflibercept).
What is the active ingredient?: Aflibercept.
Who is the labeler?: Sandoz Inc, NDC labeler code 61314. The labeler is the company responsible for the label; it may be the manufacturer, a repackager or a distributor.
What other NDCs exist for Enzeevu?: None: this is the only finished product listed under this name.
Is there a related HCPCS / J-code?: Yes: J0178, Injection, aflibercept, 1 mg. See Billing references above.

Enzeevu (Aflibercept) NDC 61314-504